Breaking News

Merck offers rhabdovirus-free insect platform for viral vaccines and gene therapy development

This will be the first non-mammalian cell line in Merck’s cell culture portfolio, allowing customers worldwide access ...

Emergex to develop novel vaccines against viral diseases

The biotech will collaborate with the Oswaldo Cruz Foundation to develop the vaccines

Landmark for AC Immune Alzheimer and Down Syndrome vaccines

The swiss clinical stage biopharmaceutical company has a broad pipeline focused on neurodegenerative diseases

Move toward cell-based manufacturing signals opening in vaccine market

Global investments and initiatives by governmental and non-governmental organisations are bringing considerable growth ...

Smallpox outbreak simulated to highlight vaccine importance

A tabletop exercise in Australia, which simulated a smallpox outbreak in the Asia-Pacific, highlighted vaccination as a ...

Research finds approach to assess Men B vaccine effectiveness

Researchers at the University of Leicester have found a new way to determine protection of Men B vaccine against ...

Cancer Research UK tests unique lung cancer vaccine

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung ...

Research hub aims to tackle the spread of new diseases

The Centre for Process Innovation will be involved in the new hub aimed at delivering high-quality vaccines at low cost, ...

Using electrons to inactivate viruses in vaccines

Four institutes associated with the Fraunhofer Gesellschaft in Germany have been investigating new techniques to make ...

A precision medicine approach to developing cancer vaccines

Modern anticancer medicines represent a significant improvement on one-size-fits-all chemotherapy, reports Dr Sarah ...

Emergex files patent in US for novel pandemic flu vaccine

The patent, ‘Reverse Peptide Vaccines’, covers the use of peptides derived from human influenza A

Scancell receives European patent for immunotherapy platform

The developer of novel immunotherapies confirmed that the European Patent Office will grant a European Patent for its ...